Clinical Data EHA26: BMS touts positive multiple myeloma data for two pipeline candidates Pharmaceutical TechnologyBMS shared Phase III data for mezigdomide and Phase I data for a CAR-T therapy at this year's EHA conference.OncologyRead full story pharminent June 17, 2026 (Last updated: June 17, 2026) Pharmaceutical Technology BMS shared Phase III data for mezigdomide and Phase I data for a CAR-T therapy at this year’s EHA conference. Oncology Read full story Post navigation Previous: FDA, Moderna appear aligned on mRNA flu shot heading into adcommNext: Altaris to acquire Simulations Plus in $375m all-cash deal Related Stories Clinical Data Novo Nordisk starts trialing lower maintenance doses of oral Wegovy pharminent August 21, 2026 Clinical Data Cancer vaccine win restores Wall Street’s faith in Moderna pharminent August 20, 2026 Clinical Data New Taiho, Cullian data heats up lung cancer drug battle pharminent August 13, 2026
